These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31582408)

  • 1. Metabolite Profiles of Incident Diabetes and Heterogeneity of Treatment Effect in the Diabetes Prevention Program.
    Chen ZZ; Liu J; Morningstar J; Heckman-Stoddard BM; Lee CG; Dagogo-Jack S; Ferguson JF; Hamman RF; Knowler WC; Mather KJ; Perreault L; Florez JC; Wang TJ; Clish C; Temprosa M; Gerszten RE;
    Diabetes; 2019 Dec; 68(12):2337-2349. PubMed ID: 31582408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum metabolite profile associated with incident type 2 diabetes in Koreans: findings from the Korean Genome and Epidemiology Study.
    Yang SJ; Kwak SY; Jo G; Song TJ; Shin MJ
    Sci Rep; 2018 May; 8(1):8207. PubMed ID: 29844477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-traditional biomarkers and incident diabetes in the Diabetes Prevention Program: comparative effects of lifestyle and metformin interventions.
    Goldberg RB; Bray GA; Marcovina SM; Mather KJ; Orchard TJ; Perreault L; Temprosa M;
    Diabetologia; 2019 Jan; 62(1):58-69. PubMed ID: 30334082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolite Profiles of Diabetes Incidence and Intervention Response in the Diabetes Prevention Program.
    Walford GA; Ma Y; Clish C; Florez JC; Wang TJ; Gerszten RE;
    Diabetes; 2016 May; 65(5):1424-33. PubMed ID: 26861782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker-defined pathways for incident type 2 diabetes and coronary heart disease-a comparison in the MONICA/KORA study.
    Huth C; Bauer A; Zierer A; Sudduth-Klinger J; Meisinger C; Roden M; Peters A; Koenig W; Herder C; Thorand B
    Cardiovasc Diabetol; 2020 Mar; 19(1):32. PubMed ID: 32164753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: results from two case-cohort studies.
    Razquin C; Ruiz-Canela M; Clish CB; Li J; Toledo E; Dennis C; Liang L; Salas-Huetos A; Pierce KA; Guasch-Ferré M; Corella D; Ros E; Estruch R; Gómez-Gracia E; Fitó M; Lapetra J; Romaguera D; Alonso-Gómez A; Serra-Majem L; Salas-Salvadó J; Hu FB; Martínez-González MA
    Cardiovasc Diabetol; 2019 Nov; 18(1):151. PubMed ID: 31722714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of cardiac stress biomarkers with incident type 2 diabetes and changes in glucose metabolism: KORA F4/FF4 study.
    Sujana C; Seissler J; Jordan J; Rathmann W; Koenig W; Roden M; Mansmann U; Herder C; Peters A; Thorand B; Then C
    Cardiovasc Diabetol; 2020 Oct; 19(1):178. PubMed ID: 33066780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimethylguanidino Valerate: A Lifestyle-Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality.
    Ottosson F; Ericson U; Almgren P; Smith E; Brunkwall L; Hellstrand S; Nilsson PM; Orho-Melander M; Fernandez C; Melander O
    J Am Heart Assoc; 2019 Oct; 8(19):e012846. PubMed ID: 31533499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of leptin and adiponectin with incident type 2 diabetes and interactions among African Americans: the Jackson heart study.
    Bidulescu A; Dinh PC; Sarwary S; Forsyth E; Luetke MC; King DB; Liu J; Davis SK; Correa A
    BMC Endocr Disord; 2020 Mar; 20(1):31. PubMed ID: 32131811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
    ; Knowler WC; Fowler SE; Hamman RF; Christophi CA; Hoffman HJ; Brenneman AT; Brown-Friday JO; Goldberg R; Venditti E; Nathan DM
    Lancet; 2009 Nov; 374(9702):1677-86. PubMed ID: 19878986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma apolipoprotein concentrations and incident diabetes in subjects with prediabetes.
    Croyal M; Wargny M; Chemello K; Chevalier C; Blanchard V; Bigot-Corbel E; Lambert G; Le May C; Hadjadj S; Cariou B
    Cardiovasc Diabetol; 2022 Feb; 21(1):21. PubMed ID: 35130909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel inflammatory markers for incident pre-diabetes and type 2 diabetes: the Rotterdam Study.
    Brahimaj A; Ligthart S; Ghanbari M; Ikram MA; Hofman A; Franco OH; Kavousi M; Dehghan A
    Eur J Epidemiol; 2017 Mar; 32(3):217-226. PubMed ID: 28258520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolites related to purine catabolism and risk of type 2 diabetes incidence; modifying effects of the TCF7L2-rs7903146 polymorphism.
    Papandreou C; Li J; Liang L; Bulló M; Zheng Y; Ruiz-Canela M; Yu E; Guasch-Ferré M; Razquin C; Clish C; Corella D; Estruch R; Ros E; Fitó M; Arós F; Serra-Majem L; Rosique N; Martínez-González MA; Hu FB; Salas-Salvadó J
    Sci Rep; 2019 Feb; 9(1):2892. PubMed ID: 30814579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations among circulating sphingolipids, β-cell function, and risk of developing type 2 diabetes: A population-based cohort study in China.
    Yun H; Sun L; Wu Q; Zong G; Qi Q; Li H; Zheng H; Zeng R; Liang L; Lin X
    PLoS Med; 2020 Dec; 17(12):e1003451. PubMed ID: 33296380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid and lipid metabolism in post-gestational diabetes and progression to type 2 diabetes: A metabolic profiling study.
    Lai M; Liu Y; Ronnett GV; Wu A; Cox BJ; Dai FF; Röst HL; Gunderson EP; Wheeler MB
    PLoS Med; 2020 May; 17(5):e1003112. PubMed ID: 32433647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs Associated With Incident Diabetes in the Diabetes Prevention Program.
    Flowers E; Aouizerat BE; Kanaya AM; Florez JC; Gong X; Zhang L
    J Clin Endocrinol Metab; 2023 May; 108(6):e306-e312. PubMed ID: 36477577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults.
    Qiu G; Zheng Y; Wang H; Sun J; Ma H; Xiao Y; Li Y; Yuan Y; Yang H; Li X; Min X; Zhang C; Xu C; Jiang Y; Zhang X; He M; Yang M; Hu Z; Tang H; Shen H; Hu FB; Pan A; Wu T
    Int J Epidemiol; 2016 Oct; 45(5):1507-1516. PubMed ID: 27694567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.
    Diabetes Prevention Program Research Group
    Lancet Diabetes Endocrinol; 2015 Nov; 3(11):866-75. PubMed ID: 26377054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle and Progression to Type 2 Diabetes in a Cohort of Workers with Prediabetes.
    Bennasar-Veny M; Fresneda S; López-González A; Busquets-Cortés C; Aguiló A; Yañez AM
    Nutrients; 2020 May; 12(5):. PubMed ID: 32466178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressive Symptoms, Antidepressant Medication Use, and Inflammatory Markers in the Diabetes Prevention Program.
    de Groot M; Marrero D; Mele L; Doyle T; Schwartz F; Mather KJ; Goldberg R; Price DW; Ma Y; Knowler WC;
    Psychosom Med; 2018; 80(2):167-173. PubMed ID: 29016549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.